MK-677 FAQ: Sourcing, Purity, Storage & Shipping

This technical MK-677 FAQ provides principal investigators and laboratory personnel with verified analytical data regarding sourcing standards, purity testing, storage requirements, and experimental handling protocols. All content relates strictly to in vitro and preclinical research applications involving ghrelin receptor agonists.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

This technical MK-677 FAQ provides principal investigators and laboratory personnel with verified analytical data regarding sourcing standards, purity testing, storage requirements, and experimental handling protocols. All content relates strictly to in vitro and preclinical research applications involving ghrelin receptor agonists.

Reviewed by PX1 Research scientific team

Key takeaways

  • MK-677 (chemically designated as Ibutamoren mesylate) is an orally active, non-peptidic growth hormone secretagogue.
  • Although frequently categorized alongside research peptides in biochemical literature, MK-677 is structurally classified as a non-peptidic spiroindoline small molecule.
  • PX1 Research enforces rigorous quality control specifications for every lot of MK-677 synthesized for laboratory distribution.
  • All research compounds distributed by PX1 Research, including MK-677, are synthesized and processed within domestic GMP-compliant manufacturing facilities in the United States.

Introduction to MK-677 and Ghrelin Receptor Agonism

MK-677 (chemically designated as Ibutamoren mesylate) is an orally active, non-peptidic growth hormone secretagogue. In preclinical models, the compound functions as a potent, selective agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), which is the endogenous receptor for ghrelin. By binding to GHS-R1a in central and peripheral tissues, MK-677 activates intracellular signaling cascades that mimic the natural growth hormone-releasing activity of ghrelin without compromising baseline endocrine balance.

Investigators evaluating growth axis modulation frequently utilize MK-677 in comparative assays alongside traditional peptide secretagogues available in our all-peptides catalog. Preclinical studies suggest that MK-677 induces sustained elevations in circulating growth hormone (GH) and insulin-like growth factor 1 (IGF-1) concentrations. Unlike short-acting peptidic secretagogues, MK-677 exhibits prolonged receptor engagement in animal models, making it a critical reference compound for studying metabolic regulation, somatotropic signaling, and nitrogen retention in laboratory settings.

Chemical Architecture and Small-Molecule Classification

Although frequently categorized alongside research peptides in biochemical literature, MK-677 is structurally classified as a non-peptidic spiroindoline small molecule. Its chemical formula is C27H36N4O5S·CH4O3S with a molecular weight of 624.77 g/mol (mesylate salt form). This distinct molecular configuration prevents rapid enzymatic degradation by circulating peptidases, allowing high oral bioavailability in animal models.

In contrast to linear or cyclic peptide chains, the spiroindoline core offers high structural rigidity. In vitro radioligand binding assays indicate that MK-677 binds GHS-R1a with high affinity ($K_i \approx 0.4 \text{ nM}$), effectively mimicking ghrelin binding while avoiding interaction with other neuroendocrine receptor families. This structural selectivity makes MK-677 a valuable tool for isolating ghrelin-mediated pathways without cross-activating corticotropin or thyroid-stimulating axes.

Analytical Purity Standards and COA Verification

PX1 Research enforces rigorous quality control specifications for every lot of MK-677 synthesized for laboratory distribution. Each batch undergoes independent analytical testing in ISO 17025-accredited facilities within the USA to confirm purity, identity, and physical integrity prior to release. Our baseline specification requires a minimum purity threshold of $\ge 98.0\%$ as verified by High-Performance Liquid Chromatography (HPLC).

To verify molecular weight and structural identity, secondary testing via Mass Spectrometry (MS) is executed in parallel with HPLC. Furthermore, chromogenic LAL assays are conducted to ensure endotoxin levels remain strictly below standard preclinical research limits ($<0.05 \text{ EU/mg}$). Laboratory personnel can independently inspect lot-specific analytical reports through our public COA search portal to ensure absolute compliance with institutional purity requirements.

USA Sourcing and Manufacturing Compliance

All research compounds distributed by PX1 Research, including MK-677, are synthesized and processed within domestic GMP-compliant manufacturing facilities in the United States. Maintaining domestic production chains guarantees strict environmental controls, standardized cleanroom environments, and complete batch traceability from raw precursor inputs to finished laboratory reagents.

Eliminating foreign re-packaging and unverified third-party brokers allows PX1 Research to eliminate batch-to-batch variability. Principal investigators and lab managers seeking large-scale reagents or consistent lot reservation for longitudinal animal protocols can coordinate customized supply lines through our dedicated wholesale account division.

Reconstitution Dynamics and Liquid Stock Preparation

For laboratory protocols requiring liquid administration or cell-culture dosing, solid MK-677 powder must be reconstituted into standardized stock solutions. MK-677 mesylate exhibits excellent solubility in polar organic solvents, achieving complete dissolution in dimethyl sulfoxide (DMSO) at concentrations up to 100 mg/mL and ethanol at up to 25 mg/mL. Solubility in standard aqueous buffers (such as PBS) is limited unless initial solubilization is performed in DMSO or ethanol prior to dilution.

When preparing experimental dilutions, lab technicians must calculate precise solvent-to-solute ratios to maintain concentration accuracy across multi-well assays. Investigators are encouraged to utilize our interactive reconstitution calculator to determine target volumes, molarities, and working stock parameters for accurate gravimetric dispensing.

Solid Formats and Pre-Measured Research Options

To support diverse experimental designs, PX1 Research provides MK-677 in both analytical raw powder form and standardized solid oral research formats. Analytical powder is ideal for custom solution preparations, mass spectrometry calibrations, and in vitro cell culture protocols requiring precise micro-gravimetric weighing.

For preclinical animal studies where uniform solid unit administration is required to eliminate liquid handling variances, researchers frequently select pre-formulated options such as MK-677 Capsules 12.5mg. These research capsules are manufactured under strict volumetric uniformity standards, providing reproducible unit quantities for controlled laboratory evaluation.

Pharmacodynamic Profiles and Preclinical Compound Comparisons

When assessing ghrelin receptor agonists and growth hormone secretagogues, researchers often compare the pharmacodynamics of MK-677 with peptidic compounds within our research library. While peptidic secretagogues such as ipamorelin, cjc-1295-no-dac, and tesamorelin target distinct nodes of the GHRH or GHS-R1a pathways, their systemic stability differs markedly from small-molecule agonists.

Preclinical comparative data illustrate these primary operational distinctions across research secretagogues:

• **MK-677:** Non-peptidic GHS-R1a agonist; orally bioavailable in animal models; prolonged biological half-life (~24 hours in preclinical models); induces sustained GH and IGF-1 elevation.

• **Ipamorelin:** Pentapeptide GHS-R1a agonist; highly selective for GH release without elevating ACTH or cortisol; requires parenteral administration; short half-life (~2 hours).

• **CJC-1295 (No DAC):** Tetrasubstituted peptide analogue of GHRH; acts synergistically with GHS-R1a agonists; rapidly cleared unless combined with albumin-binding structures.

• **Tesamorelin:** Synthetic GHRH analogue; specifically targets pituitary GHRH receptors to stimulate pulsatile GH release; peptidic structure requires reconstituted parenteral delivery.

Thermal Stability, Storage Protocols, and Handling Guidelines

MK-677 in solid powder or capsule form demonstrates high thermal stability under standard laboratory conditions. For long-term preservation (greater than 6 months), desiccated compound should be stored at -20°C in an airtight container protected from light and moisture ingress. Short- to medium-term storage (1–6 months) is optimal at 2°C to 8°C under dry conditions.

Reconstituted liquid stock solutions prepared in DMSO or ethanol should be aliquoted into amber glass vials to prevent photodegradation and stored at -20°C or -80°C. Repeated freeze-thaw cycles must be minimized, as moisture condensation can degrade compound purity over time. Always allow cold vials to equilibrate to room temperature inside a desiccator before opening to prevent water condensation on the raw material.

Fulfillment Logistics, Shipping Standards, and Compliance

PX1 Research operates centralized distribution facilities located in California and Arizona to support rapid order processing and reliable transit times for scientific institutions. Orders containing MK-677 placed Monday through Friday prior to 12:00 PM PST qualify for same-day dispatch. Compounds are securely packaged in tamper-evident, climate-buffered materials to protect reagent integrity during transit.

All materials supplied by PX1 Research are strictly designated for laboratory research use only (in vitro and preclinical animal models). They are not intended for human or veterinary use, clinical administration, diagnostic procedures, or therapeutic applications. Adherence to these compliance parameters is mandatory for all purchasing entities.

Frequently Asked Questions

What is MK-677 and what is its primary mechanism of action in research models?

MK-677 (Ibutamoren) is an orally active growth hormone secretagogue that functions as a selective non-peptide agonist of the ghrelin receptor (GHS-R1a). Preclinical studies indicate that MK-677 stimulates sustained endogenous growth hormone (GH) and insulin-like growth factor 1 (IGF-1) release without disrupting baseline cortisol or thyroxine levels. All supply options are available via our [all-peptides](/all-peptides) research catalog for analytical testing.

Is MK-677 classified as a peptide or a small molecule?

Although frequently categorized alongside GH-releasing peptides in literature, MK-677 is structurally a non-peptidic spiroindoline small molecule. Its non-peptide structure allows high oral bioavailability in preclinical models while target-binding with high affinity to GHS-R1a. Researchers exploring growth axis secretagogues often evaluate it alongside investigational peptides like [ipamorelin](/research-peptides/ipamorelin) or [cjc-1295-no-dac](/research-peptides/cjc-1295-no-dac) in laboratory comparative assays.

What purity specifications does PX1 Research require for MK-677 lots?

Every batch of MK-677 manufactured for PX1 Research undergoes rigorous testing to guarantee a minimum purity specification of ≥98.0% as determined by high-performance liquid chromatography (HPLC). Additionally, mass spectrometry (MS) confirms exact molecular identity. You can view third-party documentation directly on our verified [COA](/coa) repository to confirm batch purity prior to requisitioning laboratory reagents.

How does PX1 Research verify MK-677 quality and freedom from contaminants?

Quality verification occurs in ISO 17025-accredited, third-party analytical facilities within the USA. Each lot undergoes HPLC for purity, MS for identification, and chromogenic LAL assays to ensure endotoxin levels remain strictly below standard preclinical thresholds. Qualified institutional accounts can request full raw spectra via our [wholesale](/wholesale) portal to maintain audit-ready documentation.

What physical forms and solid formats are available for laboratory research?

PX1 Research supplies MK-677 in both high-purity raw powder and standardized solid oral research formats. For assays requiring pre-measured solid units, researchers utilize options like [MK-677 Capsules 12.5mg](/product/mk677-capsules-12-5mg) to ensure precise gravimetric dosing in preclinical protocols without manual powder measurement. All formats are intended exclusively for non-clinical laboratory evaluations.

How should MK-677 raw powder or capsule formats be stored long-term?

Desiccated MK-677 solid state formats should be stored in a cool, dark environment at 2°C to 8°C for medium-term storage, or -20°C for long-term preservation. Exposure to direct sunlight, excessive humidity, and heat must be avoided to prevent chemical oxidation or degradation of the active compound over extended experimental timelines.

What solvents are recommended for reconstituting or dissolving MK-677 in vitro?

MK-677 powder exhibits high solubility in organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, as well as moderate solubility in aqueous buffers once pre-dissolved. For preparing precise working solutions for analytical assays, investigators utilize our laboratory [reconstitution calculator](/reconstitution-calculator) to determine exact solvent-to-solute ratios and stock concentrations.

What is the target receptor affinity of MK-677 in preclinical binding assays?

In vitro radioligand binding assays show that MK-677 exhibits nanomolar affinity (Ki ≈ 0.4 nM) for the central and peripheral growth hormone secretagogue receptor type 1a (GHS-R1a). Preclinical research demonstrates that this binding activates phospholipase C-dependent signaling pathways, leading to intracellular calcium mobilization and downstream pituitary GH release.

How does MK-677 compare to peptide GH secretagogues like Ipamorelin or GHRP-6?

Unlike peptidic secretagogues such as ipamorelin or GHRP-6, which require parenteral administration due to rapid enzymatic degradation, MK-677 resists enzymatic cleavage. Comparative [preclinical research](/research) shows both classes elevate IGF-1 and GH, but MK-677 exhibits a significantly longer pharmacodynamic half-life, producing sustained elevations in GH output during animal studies.

Where is PX1 Research MK-677 manufactured and processed?

All PX1 Research compounds, including MK-677, are synthesized, processed, and packaged in domestic GMP-compliant facilities located within the United States. Stringent environmental monitoring and cleanroom controls ensure chemical uniformity, batch-to-batch consistency, and compliance with high-tier laboratory reagent standards across all compound lots.

What shipping and fulfillment timelines apply to MK-677 orders?

Standard orders containing MK-677 ship directly from our primary distribution hubs in California and Arizona. Orders placed Monday through Friday prior to 12:00 PM PST qualify for same-day dispatch. Compounds are packed in protective, temperature-stable packaging to ensure chemical integrity throughout transit to your research facility.

Are COAs provided with every MK-677 shipment?

Yes, every compound shipment includes access to lot-specific analytical documentation. Each certificate of analysis details HPLC purity percentages, mass spectrometry identification graphs, heavy metal screens, and endotoxin assay results. Researchers can verify their lot number online at any time to maintain full traceability for laboratory auditing requirements.

Can MK-677 be used in human clinical trials or personal administration?

No. MK-677 supplied by PX1 Research is strictly designated for laboratory research use only (in vitro and preclinical animal models). It is not approved for human or veterinary consumption, medical treatment, diagnosis, or therapeutic applications. Any mention of human administration or clinical self-use violates PX1 terms of service.

How does MK-677 influence IGF-1 levels in animal models?

Rodent and non-human primate research models demonstrate that daily oral administration of MK-677 yields sustained increases in circulating serum IGF-1 concentrations. Preclinical studies indicate that elevated IGF-1 levels persist over extended treatment periods without downregulating pituitary responsiveness or causing receptor desensitization in long-term observational protocols.

What is the stability of reconstituted MK-677 liquid solutions?

Liquid stock solutions of MK-677 dissolved in DMSO or ethanol remain stable for up to 6 months when stored at -20°C in airtight, amber glass vials. Aqueous dilutions should be prepared fresh prior to experimental assays to minimize hydrolysis or concentration shifts caused by solvent evaporation during multi-day testing protocols.

Does PX1 offer volume discounts or bulk quantities of MK-677 for institutional laboratories?

Yes, PX1 Research provides institutional accounts with bulk raw powder quantities and scaled packaging configurations for high-throughput screening or extended animal study protocols. Laboratory managers can submit institutional inquiries through our dedicated [wholesale](/wholesale) account portal to review volume specifications and dedicated batch reserve programs.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.